1. Home
  2. MCHP vs KVUE Comparison

MCHP vs KVUE Comparison

Compare MCHP & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Microchip Technology Incorporated

MCHP

Microchip Technology Incorporated

HOLD

Current Price

$67.17

Market Cap

36.1B

Sector

Technology

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.31

Market Cap

39.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCHP
KVUE
Founded
1989
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Specialty Chemicals
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
36.1B
39.9B
IPO Year
1993
2023

Fundamental Metrics

Financial Performance
Metric
MCHP
KVUE
Price
$67.17
$17.31
Analyst Decision
Buy
Buy
Analyst Count
21
13
Target Price
$74.43
$20.31
AVG Volume (30 Days)
9.9M
37.7M
Earning Date
11-06-2025
11-03-2025
Dividend Yield
2.71%
4.79%
EPS Growth
N/A
35.31
EPS
N/A
0.75
Revenue
$4,212,399,999.00
$15,006,000,000.00
Revenue This Year
$5.14
N/A
Revenue Next Year
$19.01
$2.81
P/E Ratio
N/A
$23.18
Revenue Growth
N/A
N/A
52 Week Low
$34.13
$14.02
52 Week High
$77.20
$25.17

Technical Indicators

Market Signals
Indicator
MCHP
KVUE
Relative Strength Index (RSI) 65.34 60.53
Support Level $66.23 $16.70
Resistance Level $69.56 $17.59
Average True Range (ATR) 2.23 0.30
MACD 1.44 0.02
Stochastic Oscillator 86.09 68.72

Price Performance

Historical Comparison
MCHP
KVUE

About MCHP Microchip Technology Incorporated

Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: